A REVIEW ON ADVANCES IN THE DEVELOPMENT OF SPERMICIDES LOADED VAGINAL DRUG DELIVERY SYSTEM: STATE OF THE ART

Authors

  • MENNA M. ABDELLATIF Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt https://orcid.org/0000-0001-9024-1972
  • MOAZ A. ELTABEEB Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt https://orcid.org/0000-0001-5918-9870
  • MOHAMED A. EL-NABARAWI Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University https://orcid.org/0000-0003-0070-1969
  • MAHMOUD H. TEAIMA Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University https://orcid.org/0000-0002-7565-301X

DOI:

https://doi.org/10.22159/ijap.2022v14i4.44925

Keywords:

vaginal drug delivery, spermicides, critical quality attributes (CQAs), high throughput production

Abstract

Spermicides are bio-actives that might immobilize/kill the sperm in the vaginal tissues inducing contraception in the female genitalia. To inhibit sperm viability, the spermicidal drug might have to inhibit the penetration of sperm through the cervical tube of the uterus as well as attack sperm present in the vaginal walls. There are several classes of spermicidal agents such as bactericides, sulfhydryl binding agents, natural compounds, and synthetic products. There are several classes of spermicidal agents that are widely reported. Spermicides could be available in different dosage forms as foams, gels, creams, films, sponges, and nanofibers. Available pharmaceutical spermicides showed particular importance for production on large scale due to the continuous need for contraception. The upscaling of a process can be performed using a quality by design approach to ensure the achievement of the similarity principle between lab-scale and industrial scale. In addition, risk evaluation is performed to recognize all high-risk factors that can negatively affect the product to build the design space. Furthermore, the knowledge of the critical quality attributes enables the selection of the appropriate settings on a larger scale to establish a product of good quality and good packaging.

Downloads

Download data is not yet available.

References

Lech MM. Spermicides 2002: an overview. Eur J Contracept Reprod Health Care. 2002;7(3):173–77.

Gupta S, Prabha V. Intravaginal delivery approaches for contraception : an overview with emphasis on gels. J Pharm Pharm Sci. 2017;20(0):270–84.

Vignini A, Buldreghini E, Nanetti L, Amoroso S, Boscaro M, Ricciardo-Lamonica G, et al. Free thiols in human spermatozoa: Are Na+/K+-ATPase, Ca2+-ATPase activities involved in sperm motility through peroxynitrite formation?. Reprod Biomed Online. 2009;18(1):132–40.

D’cruz OJ, Uckun FM. Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles. Contraception. 2001;64(2):113–23.

Nelson AL. An overview of properties of amphora (acidform) contraceptive vaginal gel. Expert Opin Drug Saf. 2018;17(9):935–43.

Moudgil P, Gupta A, Sharma A, Gupta S, Tiwary AK. Spermicidal efficacy of some membrane stabilizers. Pharmacol Rev Commun. 2002;12(4):241-48.

Jain A, Lal N, Kumar L, Verma V, Kumar R, Kumar L, et al. Novel trichomonacidal spermicides. Antimicrob Agents Chemother. 2011;55(9):4343–51.

Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003;79(4):829–43.

Naz RK, Lough ML, Barthelmess EK. Curcumin: a novel non-steroidal contraceptive with antimicrobial properties. Front Biosci (Elite Ed). 2016;8(1):113–28.

Ogbuewu IP, Unamba-Oparah IC, Odoemenam VU, Etuk IF, Okoli IC. The potentiality of medicinal plants as the source of new contraceptive principles in males. N Am J Med Sci. 2011;3(6):255–63.

Sutyak KE, Anderson RA, Dover SE, Feathergill KA, Aroutcheva AA, Faro S, et al. Spermicidal activity of the safe natural antimicrobial peptide subtilosin. Infect Dis Obstet Gynecol. 2008;2008:540758.

Aranha C, Gupta S, Reddy KVR. Contraceptive efficacy of antimicrobial peptide nisin: in vitro and in vivo studies. Contraception. 2004;69(4):333–38.

Gupta S, Kaur IP, Prabha V. Evaluation of antifertility effect of gel formulation containing sperm immobilizing factor: in vitro and in vivo studies. Eur J Pharm Sci. 2016;81:67–74.

Kaur S, Prabha V, Sarwal A. Receptor mediated agglutination of human spermatozoa by spermagglutinating factor isolated from staphylococcus aureus. J Urol. 2010;184(6):2586–90.

Maikhuri JP, Dwivedi AK, Dhar JD, Setty BS, Gupta G. Mechanism of action of some acrylophenones, quinolines and dithiocarbamate as potent, non-detergent spermicidal agents. Contraception. 2003;67(5):403–8.

Suthutvoravut S, Kamyarat O. Spermicidal effects of lemon juice and juices from other natural products. Agric Nat Resour. 2016;50(2):133–38.

Saha P, Majumdar S, Pal D, Pal BC, Kabir SN. Evaluation of spermicidal activity of MI-saponin A. Reprod Sci. 2010;17(5):454–64.

Zhou B, Qiu Z, Liu G, Liu C, Zhang J. Spermicidal and antigonococcal effects of tannins from pomegranate rind. J Med Plant Res. 2012;6(7):1334–39.

D’Cruz OJ, Dong Y, Uckun FM. Potent dual anti-HIV and spermicidal activities of novel oxovanadium (V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase. Biochem Biophys Res Commun. 2003;302(2):253–64.

D’Cruz OJ, Ghosh P, Uckun FM. Spermicidal activity of metallocene complexes containing vanadium (IV) in humans. Biol Reprod. 1998;58(6):1515–26.

Less GB, Ockwig NW, Rasmussen PG, Smith GD, Keller LM, Drach JC. Vanadium complex of 2-(2′-pyridyl)-4,5-dicyanoimidazole showing spermicidal and cytotoxic properties. Inorg Chem. 2006;45(18):7105–10.

Grimes DA, Lopez LM, Raymond EG, Halpern V, Nanda K, Schulz KF. Spermicide used alone for contraception. Cochrane Database Syst Rev. 2013;5(12):CD005218.

Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral Res. 2010;88 Suppl 1:S19–29.

Digenis GA, Nosek D, Mohammadi F, Darwazeh NB, Anwar HS, Zavos PM. Novel vaginal controlled-delivery systems incorporating coprecipitates of nonoxynol-9. Pharm Dev Technol. 1999;4(3):421–30.

Lee CH, Chien YW. Development and evaluation of a mucoadhesive drug delivery system for dual-controlled delivery of nonoxynol-9. J Control Release. 1996;39(1):93–103.

Malcolm K, Woolfson D, Russell J, Andrews C. In vitro release of nonoxynol-9 from silicone matrix intravaginal rings. J Control Release. 2003;91(3):355–64.

Daoud WM, Rajab MA, Rajab NA. Preparation, in-vitro characterization, and clinical study of propranolol hcl vaginal contraceptive hollow-type suppositories. World J Pharm Res. 2017;6(13):86-99.

Borumand M, Mortazavi SA, Azar ZJ, Teymouri Rad R. Development and in vitro evaluation of a novel contraceptive vaginal mucoadhesive propranolol hydrochloride film. J Drug Deliv Sci Technol. 2014;24(6):637–44.

Tasdighi E, Azar ZJ, Mortazavi SA. Development and in-vitro evaluation of a contraceptive vagino-adhesive propranolol hydrochloride gel. Iran J Pharm Res. 2012;11(1):13–26.

Van Heugten AJP, Vromans H. Scale up of semisolid dosage forms manufacturing based on process understanding: from lab to industrial scale. AAPS PharmSciTech. 2018;19(5):2330–34.

Ahmad S, Khabiya P, Au T, Bakhshi AR. Quality by design approach to develop stability indicating reversed-phase high-performance liquid chromatography method development for ambroxol. Asian J Pharm Clin Res. 2021;14(12):44–9.

Rajora A, Chhabra G. Quality by design approach: regulatory need, current, and future perspective. Asian J Pharm Clin Res. 2021;14(6):29–35.

Charoo NA, Rahman Z. Integrating QbD tools for flexible scale-up batch size selection for solid dosage forms. J Pharm Sci. 2020;109(3):1223–30.

Dhobale AV, Mahale AM, Shirsat M, Pethkar S, Chakote V. Recent advances in pilot plant scale up techniques-a review. Indo Am J Pharm Res. 2018;8(4):1060–68.

Das SN, Besan M. Pilot plant scale up techniques of solid dosage form (tablet): an overview. J Pharm Adv Res. 2020;3(7):918–25.

Das Neves J, Bahia MF. Gels as vaginal drug delivery systems. Int J Pharm. 2006;318(1–2):1–14.

Raval N, Tambe V, Maheshwari R, Deb PK, Tekade RK. Scale-up studies in pharmaceutical products development. In: Tekade RK, editor. Dosage form design considerations. Massachusetts: Academic Press; 2018. p. 669-700.

Fernández-Campos F, Obach M, Moreno MC, García A, González J. Pharmaceutical development of a generic corticoid semisolid formulation. J Drug Deliv Sci Technol. 2017;42:227–36.

Kumar A, Vercruysse J, Toiviainen M, Panouillot PE, Juuti M, Vanhoorne V, et al. Mixing and transport during pharmaceutical twin-screw wet granulation: experimental analysis via chemical imaging. Eur J Pharm Biopharm. 2014;87(2):279–89.

Ramanauskiene K, Zilius M, Kancauskas M, Juskaite V, Cizinauskas V, Inkeniene A, et al. Modeling and biopharmaceutical evaluation of semisolid systems with rosemary extract. Acta Pol Pharm. 2016;73(1):153–61.

Mascia S, Heider PL, Zhang H, Lakerveld R, Benyahia B, Barton PI, et al. End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. Angew Chem Int Ed Engl. 2013;52(47):12359–63.

Tran M, Wang C. Semi-solid materials for controlled release drug formulation: current status and future prospects. Front Chem Sci Eng. 2014;8(2):225–32.

Nasa P. A review on pharmaceutical packaging material. World J Pharm Res. 2014;3(5): 344-68.

Dobaria NB, Badhan AC, Mashru RC. A novel itraconazole bioadhesive film for vaginal delivery: design, optimization, and physicodynamic characterization. AAPS PharmSciTech. 2009;10(3):951–59.

Dobaria N, Mashru R. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clindamycin phosphate. Pharm Dev Technol. 2010;15(4):405–14.

Ham AS, Rohan LC, Boczar A, Yang L, Buckheit KW, Buckheit RW. Vaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection. Pharm Res. 2012;29(7):1897–907.

Nagaraju T, Gowthami R, Rajashekar M, Sandeep S, Mallesham M, Sathish D, et al. Comprehensive review on oral disintegrating films. Curr Drug Deliv. 2013;10(1):96–108.

Preis M, Woertz C, Kleinebudde P, Breitkreutz J. Oromucosal film preparations: classification and characterization methods. Expert Opin Drug Deliv. 2013;10(9):1303–17.

Cao N, Yang X, Fu Y. Effects of various plasticizers on mechanical and water vapor barrier properties of gelatin films. Food Hydrocoll. 2009;23(3):729–35.

Borges AF, Silva C, Coelho JFJ, Simões S. Oral films: current status and future perspectives: i-galenical development and quality attributes. J Control Release. 2015;206:1–19.

El-Gindy GA, El-Sayed AM, Mohamed SA, Abdel-Aal GM. Mucoadhesive vaginal tablets of natamycin for vaginal candidiasis. Bull Pharm Sci Assiut. 2003;26(1):29–40.

Yamamoto K, Shao ZJ. Process development, optimization, and scale-up: fluid-bed granulation. In: Qiu Y, Chen Y, Zhang GGZ, Yu L, Mantri RV, editors. Developing solid oral dosage forms: pharmaceutical theory and practice: second edition. Massachusetts: Academic Press; 2017. p. 777–92.

Natoli D, Levin M, Tsygan L, Liu L. Development, optimization, and scale-up of process parameters: tablet compression. In: Qiu Y, Chen Y, Zhang GGZ, Yu L, Mantri RV, editors. Developing solid oral dosage forms: pharmaceutical theory and practice: second edition. Massachusetts: Academic Press; 2017. p. 917–51.

Mitra B, Hilden J, Litster JD. Compaction mechanics of plastically deformable dry granules. Powder Technol. 2016;291:328–36.

Priyanka P, Rekha MS, Devi AS. Review on formulation and evaluation of solid lipid nanoparticles for vaginal application. Int J Pharm Pharm Sci. 2022;14(1):1–8.

Friend DR. Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections. Drug Deliv Transl Res. 2011;1(3):185–93.

Huang C, Soenen SJ, van Gulck E, Vanham G, Rejman J, Van Calenbergh S, et al. Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery. Biomaterials. 2012;33(3):962–69.

Krogstad EA, Woodrow KA. Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery. Int J Pharm. 2014;475(1-2):282–91.

Zimina M, Babich O, Prosekov A, Sukhikh S, Ivanova S, Shevchenko M, et al. Overview of global trends in classification, methods of preparation and application of bacteriocins. Antibiotics. 2020;9(9):553.

Whaley KJ, Hanes J, Shattock R, Cone RA, Friend DR. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Antiviral Res. 2010;88(Suppl 1):S55–66.

M. S, Panda SP, Buddha S, Kumari PVK, Rao YS. Proniosomes: a vesicular drug delivery system. Int J Curr Pharm Res. 2021;13(6):32–6.

Published

28-05-2022

How to Cite

ABDELLATIF, M. M., ELTABEEB, M. A., EL-NABARAWI, M. A., & H. TEAIMA, M. (2022). A REVIEW ON ADVANCES IN THE DEVELOPMENT OF SPERMICIDES LOADED VAGINAL DRUG DELIVERY SYSTEM: STATE OF THE ART. International Journal of Applied Pharmaceutics, 14(4). https://doi.org/10.22159/ijap.2022v14i4.44925

Issue

Section

Review Article(s)